These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
465 related items for PubMed ID: 19374144
1. Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues. Zhu Y, Curtis M, Qi X, Miller MD, Borroto-Esoda K. Antivir Chem Chemother; 2009; 19(4):165-76. PubMed ID: 19374144 [Abstract] [Full Text] [Related]
2. Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy. Lavocat F, Dény P, Pichoud C, Al Hawajri N, Kitrinos K, Borroto-Esoda K, Zoulim F. J Hepatol; 2013 Oct; 59(4):684-95. PubMed ID: 23742912 [Abstract] [Full Text] [Related]
3. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection. Menne S, Butler SD, George AL, Tochkov IA, Zhu Y, Xiong S, Gerin JL, Cote PJ, Tennant BC. Antimicrob Agents Chemother; 2008 Oct; 52(10):3617-32. PubMed ID: 18676881 [Abstract] [Full Text] [Related]
4. [Hepatitis B in patients with HIV infection]. Barreiro P, Martín-Carbonero L, García-Samaniego J. Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():71-9. PubMed ID: 19100234 [Abstract] [Full Text] [Related]
9. [Clinical management of patients with chronic hepatitis B virus infection]. Rodríguez M, González-Diéguez ML. Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():56-65. PubMed ID: 19100232 [Abstract] [Full Text] [Related]
10. Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication. Schinazi RF, Bassit L, Clayton MM, Sun B, Kohler JJ, Obikhod A, Arzumanyan A, Feitelson MA. Antimicrob Agents Chemother; 2012 Dec; 56(12):6186-91. PubMed ID: 22985879 [Abstract] [Full Text] [Related]
11. Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/nucleotide inhibitors. Niu C, Bao H, Tolstykh T, Micolochick Steuer HM, Murakami E, Korba B, Furman PA. Antivir Ther; 2010 Dec; 15(3):401-12. PubMed ID: 20516559 [Abstract] [Full Text] [Related]
12. Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro. Delaney WE, Yang H, Miller MD, Gibbs CS, Xiong S. Antimicrob Agents Chemother; 2004 Oct; 48(10):3702-10. PubMed ID: 15388423 [Abstract] [Full Text] [Related]
13. No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B. Corsa AC, Liu Y, Flaherty JF, Mitchell B, Fung SK, Gane E, Miller MD, Kitrinos KM. Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2106-12.e1. PubMed ID: 24929235 [Abstract] [Full Text] [Related]
17. Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection. Berg T, Marcellin P, Zoulim F, Moller B, Trinh H, Chan S, Suarez E, Lavocat F, Snow-Lampart A, Frederick D, Sorbel J, Borroto-Esoda K, Oldach D, Rousseau F. Gastroenterology; 2010 Oct; 139(4):1207-17. PubMed ID: 20600025 [Abstract] [Full Text] [Related]
18. Hepatitis B in HIV patients: what is the current treatment and what are the challenges? Soriano V, Tuma P, Vispo E, Labarga P, Fernández JV, Medrano J, Barreiro P. J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560 [Abstract] [Full Text] [Related]
19. Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success. Chien RN, Liaw YF. Best Pract Res Clin Gastroenterol; 2008 Mar; 22(6):1081-92. PubMed ID: 19187868 [Abstract] [Full Text] [Related]